MMIRF (MedMira) Common Stock: $49.87 Mil (As of Jan. 2026)


What is MedMira Common Stock?

MedMira MMIRF +302.48% Common Stock is $49.87 Mil as of Jan. 2026. The stock has 6 warning signs investors should review.

MedMira's quarterly common stock declined from Jul. 2025 ($50.16 Mil) to Oct. 2025 ($49.09 Mil) but then increased from Oct. 2025 ($49.09 Mil) to Jan. 2026 ($49.87 Mil).

MedMira's annual common stock declined from Jul. 2023 ($51.74 Mil) to Jul. 2024 ($50.07 Mil) but then increased from Jul. 2024 ($50.07 Mil) to Jul. 2025 ($50.16 Mil).

MedMira Common Stock Historical Data

* Premium members only.

The historical data trend for MedMira's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMira Common Stock Chart

MedMira Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.00 52.84 51.74 50.07 50.16

MedMira Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.72 49.12 50.16 49.09 49.87

MedMira Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $49.87 Mil mean?
MedMira (MMIRF) has a Common Stock of $49.87 Mil as of Jan. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on MedMira and its competitors.
Is MedMira's Common Stock too high?
MedMira's current Common Stock is $49.87 Mil.
How does MedMira's Common Stock compare to VRTX and REGN?
MedMira's Common Stock of $49.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on MedMira and its competitors. MedMira's current Common Stock is $49.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMira stock overvalued right now?
MedMira (MMIRF) has a current Common Stock of $49.87 Mil. The current Common Stock is $49.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For MedMira (MMIRF), the current Common Stock is $49.87 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMira Business Description

Other Exchanges MIR:Canada
Address 155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.